Mr. Budik is an accomplished executive in the biotech industry with experience in guiding strategic product and business development in both established and emerging companies. He has effectively recruited capital from angels, venture, and strategic partner financing; established R&D and clinical teams; led international projects; and ran due diligence on prospective technologies. He maintains extensive relationships in the biotech and high-tech industry, tech transfer organizations, VC’s, and professional organizations.
Mr. Budik brings to the table executive management experience with biomedical start-ups in Israel and finance at Johnson & Johnson in the US. Previously, he served as CEO at NeuroQuest, a Trendlines Medical Portfolio company, where he led the clinical validation of blood-based immune biomarkers for Alzheimer’s and ALS diseases through the recruitment of a management team with industry recognized leaders in business and clinical development, secured $1 million in financing from private and institutional investors, and partnered with key international players in the industry. Previously, he managed business development at MND Diagnostics.
Mr. Budik studied finance and biochemistry at Miami University of Ohio, contributing to research efforts in biochemistry and organic chemistry at Miami University, Ohio State University, and the University of Tennessee and completed the Lahav Executive Training program for Healthcare Entrepreneurship at Tel Aviv University.
For International Calls: